ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 20 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $650 | -99.2% | 5,609 | -93.7% | 0.00% | – |
| Q1 2021 | $83,000 | +937.5% | 88,435 | +516.6% | 0.00% | – |
| Q2 2020 | $8,000 | +14.3% | 14,343 | -26.5% | 0.00% | – |
| Q1 2020 | $7,000 | -46.2% | 19,516 | +8.3% | 0.00% | – |
| Q4 2019 | $13,000 | -38.1% | 18,016 | -40.1% | 0.00% | – |
| Q3 2019 | $21,000 | -74.7% | 30,063 | -52.9% | 0.00% | -100.0% |
| Q2 2019 | $83,000 | -52.3% | 63,823 | -22.6% | 0.00% | -50.0% |
| Q1 2019 | $174,000 | +15.2% | 82,490 | +22.6% | 0.00% | +100.0% |
| Q4 2018 | $151,000 | -44.1% | 67,305 | -12.8% | 0.00% | -50.0% |
| Q3 2018 | $270,000 | +264.9% | 77,156 | +232.5% | 0.00% | +100.0% |
| Q2 2018 | $74,000 | -58.7% | 23,203 | -54.5% | 0.00% | -50.0% |
| Q1 2018 | $179,000 | -24.8% | 51,014 | -5.8% | 0.00% | 0.0% |
| Q4 2017 | $238,000 | -48.8% | 54,127 | -39.2% | 0.00% | -50.0% |
| Q3 2017 | $465,000 | -13.1% | 88,972 | -13.5% | 0.00% | -33.3% |
| Q2 2017 | $535,000 | +1810.7% | 102,904 | +1468.9% | 0.01% | – |
| Q1 2017 | $28,000 | -49.1% | 6,559 | -62.3% | 0.00% | -100.0% |
| Q4 2016 | $55,000 | +587.5% | 17,392 | +606.4% | 0.00% | – |
| Q3 2016 | $8,000 | +700.0% | 2,462 | +1039.8% | 0.00% | – |
| Q4 2015 | $1,000 | -87.5% | 216 | -89.8% | 0.00% | – |
| Q1 2015 | $8,000 | -71.4% | 2,115 | -54.2% | 0.00% | – |
| Q4 2014 | $28,000 | +16.7% | 4,616 | -11.7% | 0.00% | – |
| Q3 2014 | $24,000 | -46.7% | 5,226 | -44.6% | 0.00% | -100.0% |
| Q2 2014 | $45,000 | +2.3% | 9,428 | +36.1% | 0.00% | 0.0% |
| Q1 2014 | $44,000 | – | 6,927 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|